ID

44719

Description

see http://clinicaltrials.gov/ct2/show/record/NCT00617669 Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer

Link

http://clinicaltrials.gov/ct2/show/record/NCT00617669

Keywords

  1. 11/15/11 11/15/11 -
  2. 3/23/14 3/23/14 - Martin Dugas
  3. 8/10/14 8/10/14 - Martin Dugas
  4. 4/13/21 4/13/21 - Dr. rer. medic Philipp Neuhaus
  5. 9/20/21 9/20/21 -
  6. 9/28/21 9/28/21 - Sarah Riepenhausen
Copyright Holder

AstraZeneca

Uploaded on

September 28, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility DRKS00005404 NCT00617669 Prostate Cancer

Eligibility NCT00617669

  1. StudyEvent: Eligibility
    1. Eligibility NCT00617669
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
18 Years and older
Description

Age

Data type

integer

Measurement units
  • years
Alias
UMLS CUI-1
C0001779
years
male
Description

Gender Male

Data type

boolean

Alias
UMLS CUI-1
C0086582
Confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) that has spread to the bone (bone metastasis)
Description

Prostate Cancer with bone metastasis

Data type

boolean

Alias
UMLS CUI-1
C0600139
UMLS CUI-2
C0153690
Increasing Prostate Specific Antigen (PSA), collected within one year of enrollment
Description

PSA increase

Data type

boolean

Alias
UMLS CUI-1
C0138741
Currently receiving treatment with surgical or medical castration
Description

Castration

Data type

boolean

Alias
UMLS CUI-1
C0007347
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI-1
C0680251
Previous treatment with chemotherapy (paclitaxel, docetaxel, and mitoxantrone). Prior targeted cancer therapies are permitted if received during a previous clinical trial
Description

Previous chemotherapy

Data type

boolean

Alias
UMLS CUI-1
C0205156
UMLS CUI-2
C0392920
Suffering from heart failure or had a myocardial infarction within last 6 months
Description

Heart disease

Data type

boolean

Alias
UMLS CUI [1,1]
C0018801
UMLS CUI [1,2]
C0155626
A history of epilepsy or seizures
Description

Epilepsy, seizures

Data type

boolean

Alias
UMLS CUI-1
C0014544
UMLS CUI-2
C0036572

Similar models

Eligibility NCT00617669

  1. StudyEvent: Eligibility
    1. Eligibility NCT00617669
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
Age
Item
18 Years and older
integer
C0001779 (UMLS CUI-1)
Gender Male
Item
male
boolean
C0086582 (UMLS CUI-1)
Prostate Cancer with bone metastasis
Item
Confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) that has spread to the bone (bone metastasis)
boolean
C0600139 (UMLS CUI-1)
C0153690 (UMLS CUI-2)
PSA increase
Item
Increasing Prostate Specific Antigen (PSA), collected within one year of enrollment
boolean
C0138741 (UMLS CUI-1)
Castration
Item
Currently receiving treatment with surgical or medical castration
boolean
C0007347 (UMLS CUI-1)
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
Previous chemotherapy
Item
Previous treatment with chemotherapy (paclitaxel, docetaxel, and mitoxantrone). Prior targeted cancer therapies are permitted if received during a previous clinical trial
boolean
C0205156 (UMLS CUI-1)
C0392920 (UMLS CUI-2)
Heart disease
Item
Suffering from heart failure or had a myocardial infarction within last 6 months
boolean
C0018801 (UMLS CUI [1,1])
C0155626 (UMLS CUI [1,2])
Epilepsy, seizures
Item
A history of epilepsy or seizures
boolean
C0014544 (UMLS CUI-1)
C0036572 (UMLS CUI-2)

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial